We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An FDA advisory committee voted to Friday in favor of the risk-benefit profile of Aimmune Therapeutics’ peanut allergy therapy Palforzia (AR101). Read More
Purdue’s tentative $12 billion settlement for its role in the opioid abuse crisis sparked strong reactions from attorneys general across the country who believe the states deserve better. Read More
An FDA inspection of Ajinomoto Althea’s San Diego, California sterile drug facility found serious problems with its equipment setup, including a filling machine conveyor belt that caused vials to fall off the belt. Read More
Dr. Reddy’s and Hospira have asked a federal appeals court to reconsider a patent infringement ruling regarding Eli Lilly’s cancer drug Alimta (permetrexed). Read More
The FDA issued a warning letter to a Costa Rican OTC drug manufacturer for testing and other violations. and , an inadequate stability program and risks of cross-contamination netted a Costa Rican OTC drug manufacturer a warning letter from the FDA. Read More